Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis. // Journal of Clinical Lipidology. – URL: https://www.sciencedirect.com/science/article/pii/S1933287426004654?dgcid=rss_sd_all
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis. Journal of Clinical Lipidology. https://www.sciencedirect.com/science/article/pii/S1933287426004654?dgcid=rss_sd_all
“Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis.” Journal of Clinical Lipidology.
@article{article53023,
title = {Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis},
journal = {Journal of Clinical Lipidology},
url = {https://www.sciencedirect.com/science/article/pii/S1933287426004654?dgcid=rss_sd_all}
}